Postoperative Cardiac Troponin I Thresholds Associated With 1-Year Cardiac Mortality After Adult Cardiac Surgery: An Attempt to Link Risk Stratification With Management Stratification in an Observational Study.


Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 03 12 2018
revised: 22 06 2019
accepted: 26 06 2019
pubmed: 11 8 2019
medline: 9 10 2020
entrez: 11 8 2019
Statut: ppublish

Résumé

Cardiac troponin (cTn) concentrations are measured routinely in some centers after cardiac surgery as part of risk stratification, but there are no data on how increased cTn concentrations could change patients' management. The aim of this study was to estimate relevant cTnI thresholds and identify potential interventions (additional monitoring/therapeutic interventions) that could be part of management changes of patients with cTnI greater than relevant thresholds. Retrospective, single-center, observational study. Bichat-Claude Bernard Hospital, Paris, France, between January 1, 2009, and December 31, 2012. Consecutive adult patients undergoing cardiac surgery. cTnI was measured on the 20th postoperative hour. Causes of death and possible interventions were determined by analysis of individual medical records. cTnI thresholds for 1-year cardiac mortality with a specificity >80% were calculated. For this study, 3,228 procedures were analyzed; 129 deaths occurred (4%), 83 of which (2.6%) were cardiac deaths. Threshold cTnI values were 4.2 µg/L for coronary artery bypass grafting (95% confidence interval [CI] 3.9-4.5) and 10.7 µg/L for non-coronary artery bypass grafting (95% CI 10.0-11.3). In multivariable analysis, the EuroSCORE II (odds ratio 1.1 [95% CI 1.06-1.13]; p < 0.001) and cTnI concentrations greater than the thresholds (odds ratio 5.62 [95% CI 3.37-9.37]; p < 0.001) were associated with significantly increased risk of death. The additive and absolute Net Reclassification Index were 0.288% and 14.1%, respectively, for a logistic model including cTnI and EuroSCORE II (area under the curve C-index 0.82 [95% CI 0.77-0.87]) compared with a model including only EuroSCORE II (area under the curve C-index 0.80 [95% CI 0.75-0.84]). Fifty-three of the 83 patients who experienced cardiac death (64%) had a cTnI concentration greater than the threshold, and an intervention was deemed possible in 47 of those 53 (89%) (mostly patients with mild postoperative cardiac dysfunction). For noncardiac deaths, 28% of patients had a cTnI concentration greater than the threshold and no interventions were deemed possible. In an attempt to evolve from risk to management stratification, this study's results identified a subgroup of patients with mild cardiac dysfunction and a cTnI concentration greater than the threshold who could be the target for interventions in future validation studies concerning changes in patient management.

Identifiants

pubmed: 31399305
pii: S1053-0770(19)30593-2
doi: 10.1053/j.jvca.2019.06.039
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3320-3330

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Sophie Provenchère (S)

Département d'Anesthésie-Réanimation, APHP, Hôpital Bichat-Claude Bernard, Paris, France; Institut National de la Santé et de la Recherche Médicale, Centre d'Investigation Clinique 1425, APHP, Hôpital Bichat-Claude Bernard, Paris, France. Electronic address: sophie.provenchere@aphp.fr.

Jean Guglielminotti (J)

Département d'Anesthésie-Réanimation, APHP, Hôpital Bichat-Claude Bernard, Paris, France; Institut National de la Santé et de la Recherche Médicale, UMR 1137, IAME, Paris, France; Department of Anesthesiology, Columbia University College of Physicians and Surgeons, New York, NY.

Aurélie Gouel-Chéron (A)

Département d'Anesthésie-Réanimation, APHP, Hôpital Bichat-Claude Bernard, Paris, France.

Edouard Bresson (E)

Département d'Anesthésie-Réanimation, APHP, Hôpital Bichat-Claude Bernard, Paris, France.

Laetitia Desplanque (L)

Département d'Anesthésie-Réanimation, APHP, Hôpital Bichat-Claude Bernard, Paris, France.

Claire Bouleti (C)

Département de Cardiologie, DHU FIRE, APHP, Hôpital Bichat-Claude Bernard, Paris, France.

Bernard Iung (B)

Département de Cardiologie, DHU FIRE, APHP, Hôpital Bichat-Claude Bernard, Paris, France; Université Paris 7-Diderot, Paris, France; Institut National de la Santé et de la Recherche Médicale 1148, Paris, France.

Philippe Montravers (P)

Département d'Anesthésie-Réanimation, APHP, Hôpital Bichat-Claude Bernard, Paris, France; Université Paris 7-Diderot, Paris, France.

Monique Dehoux (M)

Département de Biochimie Métabolique et Cellulaire, APHP, Hôpital Bichat-Claude Bernard, Paris, France; Institut National de la Santé et de la Recherche Médicale 1152, Paris, France.

Dan Longrois (D)

Département d'Anesthésie-Réanimation, APHP, Hôpital Bichat-Claude Bernard, Paris, France; Université Paris 7-Diderot, Paris, France; Institut National de la Santé et de la Recherche Médicale 1148, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH